Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Researchers uncover new findings about the role of tau in neurodegenerative disease

Utilizing cutting-edge proteomics, researchers at the Buck Institute and elsewhere have mapped the "tau interactome" uncovering new findings about the role of tau in neurodegenerative disease. Publishing in Cell, scientists found that mutant tau impacts the function of mitochondria in human neurons.

20 Jan 2022

Study: Nearly 30% of people with blinding retinal disease can safely stop eye injection therapy

In a preliminary study of 106 people with "wet" age-related macular degeneration, Johns Hopkins Medicine researchers report that as many as a third of those with the blinding retinal disease may someday be able to safely stop eye injection therapy without further vision loss.

18 Jan 2022

Health burden from fish smoking possibly impacts millions of workers in coastal Africa

Millions of workers in coastal Africa—most of them women—spend their days preserving fish by smoking them in rudimentary, wood-fired mud ovens.

12 Jan 2022

Scientists find that having one kind of autoimmune disease can lead to another

Researchers at the University of Colorado Anschutz Medical Campus have discovered that having one kind of autoimmune disease can lead to another.

4 Jan 2022

Researchers identify two new AMD drug candidates using a stem-cell-derived model

Using a stem-cell-derived model, researchers have identified two drug candidates that may slow dry age-related macular degeneration (AMD), a leading cause of blindness for which no treatment exists.

15 Dec 2021

Ophthalmology professor receives $75,000 grant to support international collaborations on eye research

Steven DeVries, MD, PhD, the David Shoch, MD, PhD, professor of Ophthalmology, has received an International Research Collaborators Award from Research to Prevent Blindness.

14 Dec 2021

Gene therapy and diabetes drug may be treatments for late-onset retinal degeneration

Scientists have discovered that gene therapy and the diabetes drug metformin may be potential treatments for late-onset retinal degeneration (L-ORD), a rare, blinding eye disease.

9 Dec 2021

UVA researchers uncover common link between lupus and macular degeneration

University of Virginia School of Medicine researchers have made a discovery linking lupus, a potentially debilitating autoimmune disorder, and macular degeneration, a leading cause of blindness.

9 Dec 2021

Infantile cataracts are more common and problematic than thought

Three days after Canyon Brown was born, the attending pediatrician discovered a problem.

8 Dec 2021

Cataract surgery associated with lower risk of dementia

Cataracts affect most older adults at risk for dementia, and now researchers are finding strong evidence that cataract surgery is associated with a lower risk of developing dementia.

6 Dec 2021

HyVIS project to develop bionic synapses for retinal prostheses

HyVIS, the European project coordinated by the IIT-Istituto Italiano di Tecnologia (Italian Institute of Technology), is about to start.

3 Dec 2021

Packing the effects of exercise into a single pill for at-risk patients

Researchers from The Australian National University have identified unique molecular signals in the body that could hold the key to developing a supplement capable of administering the health benefits of exercise to patients incapable of physical activity.

1 Dec 2021

New findings can help identify people at increased risk of hydroxychloroquine-related retinopathy

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that higher doses, longer duration of use, chronic kidney disease and Asian race could all be independent risk factors for retinopathy in people using hydroxychloroquine, an antimalarial drug commonly used to treat lupus, rheumatoid arthritis and other diseases.

1 Nov 2021

Antidepressant Prozac could offer the first treatment for atrophic macular degeneration

An antidepressant best known as Prozac could offer the first treatment for the leading cause of blindness among people over 50, new research from the University of Virginia School of Medicine suggests.

21 Oct 2021

Australian researchers hope to switch on sight with new gene therapy

Australian researchers are developing a new gene therapy which they hope will ‘switch on sight’ by regenerating light-sensing photoreceptor cells in the retina at the back of the eye.

7 Oct 2021

Damaging DNA builds up in the eyes to drive blinding age-related macular degeneration

Damaging DNA builds up in the eyes of patients with geographic atrophy, an untreatable, poorly understood form of age-related macular degeneration that causes blindness, new research from the University of Virginia School of Medicine reveals.

1 Oct 2021

Reading ability closely linked to altered retinal structure in geographic atrophy

In geographic atrophy, a late form of age-related macular degeneration (AMD), reading ability is closely related to the altered retinal structure.

30 Sep 2021

Buck Institute receives $14 million NIH grant to focus on one of the major drivers of aging

Buck Institute professors Judith Campisi, PhD and Lisa Ellerby PhD, have been awarded a $14.3 million grant from the NIH's National Institute of Aging to study cellular senescence, one of the major hallmarks of aging, as a driver of Alzheimer's disease and other age-related dementias.

29 Sep 2021

Eye conditions linked to increased risk of dementia

Age-related macular degeneration, cataract and diabetes-related eye disease are linked to an increased risk of dementia, suggests research published online in the British Journal of Ophthalmology.

14 Sep 2021

Light therapy may speed up the healing of burns by activating growth protein

Light therapy may accelerate the healing of burns, according to a University at Buffalo-led study.

6 Aug 2021

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Researchers uncover new findings about the role of tau in neurodegenerative disease

Study: Nearly 30% of people with blinding retinal disease can safely stop eye injection therapy

Health burden from fish smoking possibly impacts millions of workers in coastal Africa

Scientists find that having one kind of autoimmune disease can lead to another

Researchers identify two new AMD drug candidates using a stem-cell-derived model

Ophthalmology professor receives $75,000 grant to support international collaborations on eye research

Gene therapy and diabetes drug may be treatments for late-onset retinal degeneration

UVA researchers uncover common link between lupus and macular degeneration

Infantile cataracts are more common and problematic than thought

Cataract surgery associated with lower risk of dementia

HyVIS project to develop bionic synapses for retinal prostheses

Packing the effects of exercise into a single pill for at-risk patients

New findings can help identify people at increased risk of hydroxychloroquine-related retinopathy

Antidepressant Prozac could offer the first treatment for atrophic macular degeneration

Australian researchers hope to switch on sight with new gene therapy

Damaging DNA builds up in the eyes to drive blinding age-related macular degeneration

Reading ability closely linked to altered retinal structure in geographic atrophy

Buck Institute receives $14 million NIH grant to focus on one of the major drivers of aging

Eye conditions linked to increased risk of dementia

Light therapy may speed up the healing of burns by activating growth protein

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in